| Name | Title | Contact Details |
|---|
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
The Abbott Union Free School District provides programs especially designed for children with special needs.
Medical Practice Innovations is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Market Drugs Medical is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We`re a group of insanely passionate wellness professionals who are lucky enough to do what we love every single day. We help companies increase the health and performance of their workplace by building tailored, high-touch corporate wellness programs. By encouraging employees to engage, challenge themselves and have fun we strive to boost well being not just during work hours, but wherever the other 128 hours of each week may take them.